Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.34 USD | -0.01% | +1.89% | -4.29% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.32M 361M |
---|---|---|---|---|---|
Net income 2024 * | -14M -1.17B | Net income 2025 * | -18M -1.5B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.65
x | P/E ratio 2025 * |
-1.3
x | Employees | 6 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.17% |
Latest transcript on Artelo Biosciences, Inc.
1 day | -0.01% | ||
1 week | +1.89% | ||
Current month | -9.47% | ||
1 month | -8.85% | ||
3 months | -8.23% | ||
6 months | -2.32% | ||
Current year | -4.29% |
Managers | Title | Age | Since |
---|---|---|---|
Gregory Gorgas
CEO | Chief Executive Officer | 61 | 03/17/03 |
Andy Yates
CTO | Chief Tech/Sci/R&D Officer | - | 01/21/01 |
Steven D. Reich
CTO | Chief Tech/Sci/R&D Officer | - | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Connie Matsui
CHM | Chairman | 70 | 02/17/02 |
Steven Kelly
BRD | Director/Board Member | 59 | 02/17/02 |
Gregory Reyes
BRD | Director/Board Member | 70 | 30/20/30 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 1.34 | -0.01% | 5,726 |
25/24/25 | 1.34 | -0.13% | 5,281 |
24/24/24 | 1.342 | +2.43% | 5,411 |
23/24/23 | 1.31 | +0.74% | 15,876 |
22/24/22 | 1.3 | -1.11% | 3,574 |
Delayed Quote Nasdaq, April 27, 2024 at 02:00 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.29% | 4.32M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ARTL Stock